No. | Subject | Course | Topic | User Category | Telecast Date / Day | Telecast Time | Repeat Time |
---|---|---|---|---|---|---|---|
1 | Engineering | interactomics using Genomics and proteomics technologies | Technology- Bioinformatics and data analysis-II | 08:00:00 - 08:44:43 || | |||
2 | Engineering | for Breast Cancer | 08:44:43 - 10:03:51 || | ||||
3 | Engineering | Carbohydrates (Part 3) | 10:03:51 - 10:31:47 || | ||||
4 | Engineering | 10:31:47 - 11:01:51 || | |||||
5 | Engineering | Characterization and Application | modelling (FEM) of soft tissues (continued.)_2 | 11:01:51 - 12:00:00 || | |||
6 | Engineering | interactomics using Genomics and proteomics technologies | Technology- Bioinformatics and data analysis-I | 12:00:00 - 12:37:21 || | |||
7 | Engineering | Applications in Cancer | 12:37:21 - 13:52:05 || | ||||
8 | Engineering | Carbohydrates (Part 1) | 13:52:05 - 14:30:37 || | ||||
9 | Engineering | Carbohydrates (Part 2) | 14:30:37 - 15:03:18 || | ||||
10 | Engineering | Characterization and Application | modelling (FEM) of soft tissues (continued)_1 | 15:03:18 - 16:00:00 || | |||
11 | Engineering | interactomics using Genomics and proteomics technologies | Next-Generation Sequencing Technology- Ion Torrentâ„¢ | 16:00:00 - 16:46:56 || | |||
12 | Engineering | 16:46:56 - 17:54:30 || | |||||
13 | Engineering | acids | 17:54:30 - 19:02:14 || | ||||
14 | Engineering | Characterization and Application | modelling (FEM) of soft tissues | 19:02:14 - 20:00:00 || | |||
15 | Engineering | interactomics using Genomics and proteomics technologies | Plasmon Resonance- Principles and Assays-II | 20:00:00 - 20:40:17 || | |||
16 | Engineering | interactomics using Genomics and proteomics technologies | SPR in unravelling domain motif interactions of proteasomal assembly chaperones | 20:40:17 - 21:17:25 || | |||
17 | Engineering | cancer immunotherapy - Part 2 | 21:17:25 - 22:09:12 || | ||||
18 | Engineering | Division and regulation | 22:09:12 - 23:00:26 || | ||||
19 | Engineering | Characterization and Application | tissue simulants (continued) | 23:00:26 - 00:00:00 || | |||
20 | Engineering | interactomics using Genomics and proteomics technologies | Plasmon Resonance- Principles and Assays-I | 00:00:00 - 00:42:58 (2024-10-31) || | |||
21 | Engineering | Microenvironment - Immune Checkpoint Inhabitors | 00:42:58 - 01:15:42 (2024-10-31) || | ||||
22 | Engineering | Cells (Part 3) | 01:15:42 - 01:59:31 (2024-10-31) || | ||||
23 | Engineering | Characterization and Application | with tissues (continued) | 01:59:31 - 03:01:12 (2024-10-31) || | |||
24 | Engineering | Characterization and Application | tissue simulants | 03:01:12 - 04:00:00 (2024-10-31) || | |||
25 | Engineering | interactomics using Genomics and proteomics technologies | Biomolecular interaction analytics using MicroScale Thermophoresis | 04:00:00 - 05:11:57 (2024-10-31) || | |||
26 | Engineering | cancer immunotherapy - Part 1 | 05:11:57 - 06:24:26 (2024-10-31) || | ||||
27 | Engineering | Cells (Part 2) | 06:24:26 - 06:59:11 (2024-10-31) || | ||||
28 | Engineering | Characterization and Application | with tissues | 06:59:11 - 08:00:00 (2024-10-31) || | |||
29 | Engineering | interactomics using Genomics and proteomics technologies | Technology- Bioinformatics and data analysis-I | 08:00:00 - 08:37:21 || | |||
30 | Engineering | Applications in Cancer | 08:37:21 - 09:52:05 || | ||||
31 | Engineering | Carbohydrates (Part 1) | 09:52:05 - 10:30:37 || | ||||
32 | Engineering | Carbohydrates (Part 2) | 10:30:37 - 11:03:18 || | ||||
33 | Engineering | Characterization and Application | modelling (FEM) of soft tissues (continued)_1 | 11:03:18 - 12:00:00 || | |||
34 | Engineering | interactomics using Genomics and proteomics technologies | Next-Generation Sequencing Technology- Ion Torrentâ„¢ | 12:00:00 - 12:46:56 || | |||
35 | Engineering | 12:46:56 - 13:54:30 || | |||||
36 | Engineering | acids | 13:54:30 - 15:02:14 || | ||||
37 | Engineering | Characterization and Application | modelling (FEM) of soft tissues | 15:02:14 - 16:00:00 || | |||
38 | Engineering | interactomics using Genomics and proteomics technologies | Plasmon Resonance- Principles and Assays-II | 16:00:00 - 16:40:17 || | |||
39 | Engineering | interactomics using Genomics and proteomics technologies | SPR in unravelling domain motif interactions of proteasomal assembly chaperones | 16:40:17 - 17:17:25 || | |||
40 | Engineering | cancer immunotherapy - Part 2 | 17:17:25 - 18:09:12 || | ||||
41 | Engineering | Division and regulation | 18:09:12 - 19:00:26 || | ||||
42 | Engineering | Characterization and Application | tissue simulants (continued) | 19:00:26 - 20:00:00 || | |||
43 | Engineering | interactomics using Genomics and proteomics technologies | Plasmon Resonance- Principles and Assays-I | 20:00:00 - 20:42:58 || | |||
44 | Engineering | Microenvironment - Immune Checkpoint Inhabitors | 20:42:58 - 21:15:42 || | ||||
45 | Engineering | Cells (Part 3) | 21:15:42 - 21:59:31 || | ||||
46 | Engineering | Characterization and Application | with tissues (continued) | 21:59:31 - 23:01:12 || | |||
47 | Engineering | Characterization and Application | tissue simulants | 23:01:12 - 00:00:00 || | |||
48 | Engineering | interactomics using Genomics and proteomics technologies | Biomolecular interaction analytics using MicroScale Thermophoresis | 00:00:00 - 01:11:57 (2024-11-01) || | |||
49 | Engineering | cancer immunotherapy - Part 1 | 01:11:57 - 02:24:26 (2024-11-01) || | ||||
50 | Engineering | Cells (Part 2) | 02:24:26 - 02:59:11 (2024-11-01) || | ||||
51 | Engineering | Characterization and Application | with tissues | 02:59:11 - 04:00:00 (2024-11-01) || | |||
52 | Engineering | interactomics using Genomics and proteomics technologies | Biomolecular interactions using Bio-Layer Interferometry (BLI)-II | 04:00:00 - 05:09:58 (2024-11-01) || | |||
53 | Engineering | Methods - 3 | 05:09:58 - 06:17:20 (2024-11-01) || | ||||
54 | Engineering | (Part 3) | 06:17:20 - 07:10:12 (2024-11-01) || | ||||
55 | Engineering | Cells (Part 1) | 07:10:12 - 08:00:00 (2024-11-01) || | ||||
56 | Engineering | Biotechnology | Practices (Part 1) | 08:00:00 - 08:40:06 || | |||
57 | Engineering | Biotechnology | Practices (Part 2) | 08:40:06 - 09:08:59 || | |||
58 | Engineering | Biomedical Imaging Systems | 09:08:59 - 10:00:00 || | ||||
59 | Engineering | interactomics using Genomics and proteomics technologies | Technology- Bioinformatics and data analysis-I | 10:00:00 - 10:37:21 || | |||
60 | Engineering | Applications in Cancer | 10:37:21 - 11:52:05 || | ||||
61 | Engineering | Carbohydrates (Part 1) | 11:52:05 - 12:30:37 || | ||||
62 | Engineering | Carbohydrates (Part 2) | 12:30:37 - 13:03:18 || | ||||
63 | Engineering | Characterization and Application | modelling (FEM) of soft tissues (continued)_1 | 13:03:18 - 14:00:00 || | |||
64 | Engineering | interactomics using Genomics and proteomics technologies | Next-Generation Sequencing Technology- Ion Torrentâ„¢ | 14:00:00 - 14:46:56 || | |||
65 | Engineering | 14:46:56 - 15:54:30 || | |||||
66 | Engineering | acids | 15:54:30 - 17:02:14 || | ||||
67 | Engineering | Characterization and Application | modelling (FEM) of soft tissues | 17:02:14 - 18:00:00 || | |||
68 | Engineering | interactomics using Genomics and proteomics technologies | Plasmon Resonance- Principles and Assays-II | 18:00:00 - 18:40:17 || | |||
69 | Engineering | interactomics using Genomics and proteomics technologies | SPR in unravelling domain motif interactions of proteasomal assembly chaperones | 18:40:17 - 19:17:25 || | |||
70 | Engineering | cancer immunotherapy - Part 2 | 19:17:25 - 20:09:12 || | ||||
71 | Engineering | Division and regulation | 20:09:12 - 21:00:26 || | ||||
72 | Engineering | Characterization and Application | tissue simulants (continued) | 21:00:26 - 22:00:00 || | |||
73 | Engineering | interactomics using Genomics and proteomics technologies | Plasmon Resonance- Principles and Assays-I | 22:00:00 - 22:42:58 || | |||
74 | Engineering | Microenvironment - Immune Checkpoint Inhabitors | 22:42:58 - 23:15:42 || | ||||
75 | Engineering | Cells (Part 3) | 23:15:42 - 23:59:31 || | ||||
76 | Engineering | Characterization and Application | with tissues (continued) | 23:59:31 - 01:01:12 || | |||
77 | Engineering | Characterization and Application | tissue simulants | 01:01:12 - 02:00:00 (2024-11-02) || | |||
78 | Engineering | interactomics using Genomics and proteomics technologies | Biomolecular interaction analytics using MicroScale Thermophoresis | 02:00:00 - 03:11:57 (2024-11-02) || | |||
79 | Engineering | cancer immunotherapy - Part 1 | 03:11:57 - 04:24:26 (2024-11-02) || | ||||
80 | Engineering | Cells (Part 2) | 04:24:26 - 04:59:11 (2024-11-02) || | ||||
81 | Engineering | Characterization and Application | with tissues | 04:59:11 - 06:00:00 (2024-11-02) || | |||
82 | Engineering | Biotechnology | Practices (Part 1) | 06:00:00 - 06:40:06 (2024-11-02) || | |||
83 | Engineering | Biotechnology | Practices (Part 2) | 06:40:06 - 07:08:59 (2024-11-02) || | |||
84 | Engineering | Biomedical Imaging Systems | 07:08:59 - 08:00:00 (2024-11-02) || | ||||
85 | Engineering | Biotechnology | Laboratory Instruments (Part 1) | 08:00:00 - 09:05:54 || | |||
86 | Engineering | Biotechnology | Laboratory Instruments (Part 2) | 09:05:54 - 10:00:00 || | |||
87 | Engineering | interactomics using Genomics and proteomics technologies | Technology- Bioinformatics and data analysis-I | 10:00:00 - 10:37:21 || | |||
88 | Engineering | Applications in Cancer | 10:37:21 - 11:52:05 || | ||||
89 | Engineering | Carbohydrates (Part 1) | 11:52:05 - 12:30:37 || | ||||
90 | Engineering | Carbohydrates (Part 2) | 12:30:37 - 13:03:18 || | ||||
91 | Engineering | Characterization and Application | modelling (FEM) of soft tissues (continued)_1 | 13:03:18 - 14:00:00 || | |||
92 | Engineering | interactomics using Genomics and proteomics technologies | Next-Generation Sequencing Technology- Ion Torrentâ„¢ | 14:00:00 - 14:46:56 || | |||
93 | Engineering | 14:46:56 - 15:54:30 || | |||||
94 | Engineering | acids | 15:54:30 - 17:02:14 || | ||||
95 | Engineering | Characterization and Application | modelling (FEM) of soft tissues | 17:02:14 - 18:00:00 || | |||
96 | Engineering | interactomics using Genomics and proteomics technologies | Plasmon Resonance- Principles and Assays-II | 18:00:00 - 18:40:17 || | |||
97 | Engineering | interactomics using Genomics and proteomics technologies | SPR in unravelling domain motif interactions of proteasomal assembly chaperones | 18:40:17 - 19:17:25 || | |||
98 | Engineering | cancer immunotherapy - Part 2 | 19:17:25 - 20:09:12 || | ||||
99 | Engineering | Division and regulation | 20:09:12 - 21:00:26 || | ||||
100 | Engineering | Characterization and Application | tissue simulants (continued) | 21:00:26 - 22:00:00 || | |||
101 | Engineering | interactomics using Genomics and proteomics technologies | Plasmon Resonance- Principles and Assays-I | 22:00:00 - 22:42:58 || | |||
102 | Engineering | Microenvironment - Immune Checkpoint Inhabitors | 22:42:58 - 23:15:42 || | ||||
103 | Engineering | Cells (Part 3) | 23:15:42 - 23:59:31 || | ||||
104 | Engineering | Characterization and Application | with tissues (continued) | 23:59:31 - 01:01:12 || | |||
105 | Engineering | Characterization and Application | tissue simulants | 01:01:12 - 02:00:00 (2024-11-03) || | |||
106 | Engineering | interactomics using Genomics and proteomics technologies | Biomolecular interaction analytics using MicroScale Thermophoresis | 02:00:00 - 03:11:57 (2024-11-03) || | |||
107 | Engineering | cancer immunotherapy - Part 1 | 03:11:57 - 04:24:26 (2024-11-03) || | ||||
108 | Engineering | Cells (Part 2) | 04:24:26 - 04:59:11 (2024-11-03) || | ||||
109 | Engineering | Characterization and Application | with tissues | 04:59:11 - 06:00:00 (2024-11-03) || | |||
110 | Engineering | Biotechnology | Practices (Part 1) | 06:00:00 - 06:40:06 (2024-11-03) || | |||
111 | Engineering | Biotechnology | Practices (Part 2) | 06:40:06 - 07:08:59 (2024-11-03) || | |||
112 | Engineering | Biomedical Imaging Systems | 07:08:59 - 08:00:00 (2024-11-03) || | ||||
113 | Engineering | Biotechnology | Laboratory Instruments (Part 3) | 08:00:00 - 08:38:44 || | |||
114 | Engineering | Biomedical Imaging Systems | 08:38:44 - 10:00:00 || | ||||
115 | Engineering | Biotechnology | Laboratory Instruments (Part 1) | 10:00:00 - 11:05:54 || | |||
116 | Engineering | Biotechnology | Laboratory Instruments (Part 2) | 11:05:54 - 12:00:00 || | |||
117 | Engineering | interactomics using Genomics and proteomics technologies | Technology- Bioinformatics and data analysis-I | 12:00:00 - 12:37:21 || | |||
118 | Engineering | Applications in Cancer | 12:37:21 - 13:52:05 || | ||||
119 | Engineering | Carbohydrates (Part 1) | 13:52:05 - 14:30:37 || | ||||
120 | Engineering | Carbohydrates (Part 2) | 14:30:37 - 15:03:18 || | ||||
121 | Engineering | Characterization and Application | modelling (FEM) of soft tissues (continued)_1 | 15:03:18 - 16:00:00 || | |||
122 | Engineering | interactomics using Genomics and proteomics technologies | Next-Generation Sequencing Technology- Ion Torrentâ„¢ | 16:00:00 - 16:46:56 || | |||
123 | Engineering | 16:46:56 - 17:54:30 || | |||||
124 | Engineering | acids | 17:54:30 - 19:02:14 || | ||||
125 | Engineering | Characterization and Application | modelling (FEM) of soft tissues | 19:02:14 - 20:00:00 || | |||
126 | Engineering | interactomics using Genomics and proteomics technologies | Plasmon Resonance- Principles and Assays-II | 20:00:00 - 20:40:17 || | |||
127 | Engineering | interactomics using Genomics and proteomics technologies | SPR in unravelling domain motif interactions of proteasomal assembly chaperones | 20:40:17 - 21:17:25 || | |||
128 | Engineering | cancer immunotherapy - Part 2 | 21:17:25 - 22:09:12 || | ||||
129 | Engineering | Division and regulation | 22:09:12 - 23:00:26 || | ||||
130 | Engineering | Characterization and Application | tissue simulants (continued) | 23:00:26 - 00:00:00 || | |||
131 | Engineering | interactomics using Genomics and proteomics technologies | Plasmon Resonance- Principles and Assays-I | 00:00:00 - 00:42:58 (2024-11-05) || | |||
132 | Engineering | Microenvironment - Immune Checkpoint Inhabitors | 00:42:58 - 01:15:42 (2024-11-05) || | ||||
133 | Engineering | Cells (Part 3) | 01:15:42 - 01:59:31 (2024-11-05) || | ||||
134 | Engineering | Characterization and Application | with tissues (continued) | 01:59:31 - 03:01:12 (2024-11-05) || | |||
135 | Engineering | Characterization and Application | tissue simulants | 03:01:12 - 04:00:00 (2024-11-05) || | |||
136 | Engineering | interactomics using Genomics and proteomics technologies | Biomolecular interaction analytics using MicroScale Thermophoresis | 04:00:00 - 05:11:57 (2024-11-05) || | |||
137 | Engineering | cancer immunotherapy - Part 1 | 05:11:57 - 06:24:26 (2024-11-05) || | ||||
138 | Engineering | Cells (Part 2) | 06:24:26 - 06:59:11 (2024-11-05) || | ||||
139 | Engineering | Characterization and Application | with tissues | 06:59:11 - 08:00:00 (2024-11-05) || | |||
140 | Engineering | Biotechnology | Buffer Preparation | 08:00:00 - 09:04:26 || | |||
141 | Engineering | Biomedical Imaging Systems | overview | 09:04:26 - 10:00:00 || | |||
142 | Engineering | Biotechnology | Laboratory Instruments (Part 3) | 10:00:00 - 10:38:44 || | |||
143 | Engineering | Biomedical Imaging Systems | 10:38:44 - 12:00:00 || | ||||
144 | Engineering | interactomics using Genomics and proteomics technologies | Technology- Bioinformatics and data analysis-I | 12:00:00 - 12:37:21 || | |||
145 | Engineering | Applications in Cancer | 12:37:21 - 13:52:05 || | ||||
146 | Engineering | Carbohydrates (Part 1) | 13:52:05 - 14:30:37 || | ||||
147 | Engineering | Carbohydrates (Part 2) | 14:30:37 - 15:03:18 || | ||||
148 | Engineering | Characterization and Application | modelling (FEM) of soft tissues (continued)_1 | 15:03:18 - 16:00:00 || | |||
149 | Engineering | interactomics using Genomics and proteomics technologies | Next-Generation Sequencing Technology- Ion Torrentâ„¢ | 16:00:00 - 16:46:56 || | |||
150 | Engineering | 16:46:56 - 17:54:30 || | |||||
151 | Engineering | acids | 17:54:30 - 19:02:14 || | ||||
152 | Engineering | Characterization and Application | modelling (FEM) of soft tissues | 19:02:14 - 20:00:00 || | |||
153 | Engineering | interactomics using Genomics and proteomics technologies | Plasmon Resonance- Principles and Assays-II | 20:00:00 - 20:40:17 || | |||
154 | Engineering | interactomics using Genomics and proteomics technologies | SPR in unravelling domain motif interactions of proteasomal assembly chaperones | 20:40:17 - 21:17:25 || | |||
155 | Engineering | cancer immunotherapy - Part 2 | 21:17:25 - 22:09:12 || | ||||
156 | Engineering | Division and regulation | 22:09:12 - 23:00:26 || | ||||
157 | Engineering | Characterization and Application | tissue simulants (continued) | 23:00:26 - 00:00:00 || | |||
158 | Engineering | interactomics using Genomics and proteomics technologies | Plasmon Resonance- Principles and Assays-I | 00:00:00 - 00:42:58 (2024-11-06) || | |||
159 | Engineering | Microenvironment - Immune Checkpoint Inhabitors | 00:42:58 - 01:15:42 (2024-11-06) || | ||||
160 | Engineering | Cells (Part 3) | 01:15:42 - 01:59:31 (2024-11-06) || | ||||
161 | Engineering | Characterization and Application | with tissues (continued) | 01:59:31 - 03:01:12 (2024-11-06) || | |||
162 | Engineering | Characterization and Application | tissue simulants | 03:01:12 - 04:00:00 (2024-11-06) || | |||
163 | Engineering | interactomics using Genomics and proteomics technologies | Biomolecular interaction analytics using MicroScale Thermophoresis | 04:00:00 - 05:11:57 (2024-11-06) || | |||
164 | Engineering | cancer immunotherapy - Part 1 | 05:11:57 - 06:24:26 (2024-11-06) || | ||||
165 | Engineering | Cells (Part 2) | 06:24:26 - 06:59:11 (2024-11-06) || | ||||
166 | Engineering | Characterization and Application | with tissues | 06:59:11 - 08:00:00 (2024-11-06) || |
Swayam Prabha copyright © 2024 INFLIBNET Centre. All rights reserved.